Abstract
Hodgkin’s lymphoma (HL) constitutes around 30% of all lymphomas(1). IPS is used for the risk stratification of advanced stage HL but it lack applicability to the early stage cases(1)..In this prospective cohort study, we aim to confirm the relationship between vitaminD3 levels with treatment response (interim as well as end of treatment) of HL treated with the standard chemotherapy and radiotherapy regimens. A total of 50 patients were recruited over a period of 18 months and the patients were followed up in the hematology clinic and interim treatment responses as well as end of treatment response were assessed. Correlation of the vitaminD3 levels and the treatment response showed that the low levels of vitaminD3 were associated with more advanced stages. Univariate analysis showed that there was no significant correlation of interim treatment response as well as end of treatment response with vitamin D3 levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
